Final Results

RNS Number : 8353N
Bodycote PLC
25 February 2009
 



BODYCOTE PLC


PRELIMINARY RESULTS 


FOR THE YEAR ENDED 31 DECEMBER 2008


EMBARGOED UNTIL 0700 HOURS 25 FEBRUARY 2009


Financial highlights


  • Revenue from continuing operations increased by 18.6% to £551.8m (2007: £465.2m)

  • Headline operating profit 1 rose 1.3% to £71.2m (2007: £70.3m)

  • Operating loss (post exceptional charges of £122.9m) from continuing operations of £51.7m (2007: profit £63.1m)

  • Basic headline earnings per share from continuing operations increased 5.4% to 17.5p (2007: 16.6p)

  • Basic earnings per share from continuing and discontinued operations increased 190.4% to 48.2p (2007: 16.6p)

  • Full year total proposed dividend 8.3 pence per share (2007: 8.0p), up 3.8% 


Operational highlights


  • Disposal of Testing business for £420m

  • 40 pence per share (£129m) return of cash to shareholders, £21m additional contribution to UK pension fund, Group balance sheet significantly strengthened

  • Stephen Harris appointed as Chief Executive


Restructuring programme


  • Major restructuring and reshaping programme launched

- £35m cash cost to deliver annualised cost savings of £18m

  • 31 facilities to be consolidated or closed

  • Total restructuring cost in 2008 of £77.6m with anticipated £8m expected to follow

  • Goodwill impairment of £31.9m


Commenting on the results, Stephen Harris, Chief Executive said: 

        

Following the sale of the Testing activities Bodycote is a focused business with a strong balance sheet. While automotive markets have softened, demand from aerospace, power generation and oil gas markets remain steady.  


In response to the difficult economic and trading environment, the business is being restructured to ensure it remains strong throughout the downturn and is well positioned to benefit when trading conditions improve.  The focus of the restructuring is to both drive down the cost base of the business while at the same time reshaping it to concentrate on those areas that present strong growth opportunities for the future.


Despite the uncertain economic environmentwe remain confident in the medium and long term prospects for the Group.


1    a detailed reconciliation is provided in the Group Business Review Financial Results 2008 section

2    a detailed reconciliation is provided in Note 4 to this announcement



  Overview


2008 was a year of transformation for Bodycote, both in terms of the business and also the Board of Directors.


The Group revenue from continuing operations increased by 18.6% to £551.8m and headline operating profit from continuing operations was up 1.3% to £71.2m. Headline profit before tax for the Group was £67.6m compared to £67.8m in 2007. 


In anticipation of a prolonged economic downturn, the Board has initiated a major re-organisation of the remaining Thermal Processing activities to achieve a slimmer fixed cost base and focus on higher value added services. This has resulted in exceptional charges of £122.9m and consequently there was an operating loss for the year of £51.7m compared to an operating profit of £63.1m in 2007.


As a result of an in-depth strategic review early in 2008, the Board decided to focus the Group on its core Thermal Processing operations and dispose of the Testing business, which was originally acquired in 1990 and expanded considerably in recent years. The ensuing auction process was highly competitive and resulted in a cash sale of the Testing business for a price of £419.7m, giving rise to a pre-tax exceptional profit of £199.3m. The Board considered carefully the appropriate use of proceeds in light of the deteriorating economic climate. As a result Bodycote returned £128.8m of the proceeds to shareholders in December 2008 through a return of capital and concurrent share capital reorganisation, made an additional contribution to the UK pension scheme of £21.0m and significantly strengthened the Group's balance sheet. The value realised from the sale of the Testing business (which accounted for 30% of annualised Group headline profit at the time of the sale) approximated the market value of the whole of Bodycote at the point of completion.


Following the sale of the Testing business, more than 7,000 employees continue to provide high quality services from over 190 locations in 27 countries, serving several tens of thousands of customers. In 2008 the Thermal Processing business delivered 77% of Group sales compared to 73% in 2007 and saw its sales increase by 18.6%. The Group operates in two principal business areas: Heat Treatment and Hot Isostatic Pressing (HIP). During 2008 Bodycote has continued to execute its strategy of developing its presence in emerging markets and increasing the proportion of high added value services in developed economies. The disposal of Testing for a consideration of £419.7m brought net cash proceeds, after expenses and tax, of £378.2m and an exceptional profit after tax of £177.4m. In order to accelerate the move away from lower added value work and to reduce the Group's cost base in light of the global macro economic downturn, the Board also initiated a significant restructuring of the continuing Thermal Processing business. Headline operating profit of the continuing business was £71.2m, but after allowing for exceptional costs of restructuring and asset impairment there was a statutory operating loss for continuing operations of £51.7m. More information and a reconciliation are provided below. 


Macro-economic environment 


Most of the countries in which Bodycote operates started to experience significant reductions in demand in the second half of 2008 and, although not specific to Bodycote, the Group has not been immune to falling production rates. In anticipation of the downturn in demand, cost reduction programmes aimed at matching costs with revenues are being implemented.  Bodycote's greatest cost is people and a Group wide reduction in the number of temporary and short-term workers is ongoing. Further far reaching restructuring actions are underway, which are expected to result in annualised cost savings of approximately £18m, some of which accrued in 2008, about half will be a benefit in 2009 and the full impact will be felt in 2010.  Pay rates tend to be settled in the early part of the year and in 2008 the pay awards averaged 3.5%. This is expected to be significantly lower in 2009.  Headcount in Thermal Processing peaked in 2008 at 7,736. By year-end this figure had fallen to 7,001.  Energy prices have remained near record highs during the year with different countries experiencing varying levels of movement in unit costs. Overall, energy costs increased by one percent of sales, year on year.  As a service provider Bodycote is ultimately subject to changes in production throughputs and market demand for its products. The sectors that the Group serves which have been particularly challenging in 2008 are automotive, heavy truck, construction and automotive related tooling. Aerospace, power generation and oil & gas demand have remained steady.  


Long term strategy and business objectives 


The Group is now focused on Thermal Processing. The objective of the Group is to provide superior shareholder returns through the provision of thermal processing services, on a global basis, that are highly valued by the Group's customers. Bodycote aims to achieve this in safe working conditions and with minimal environmental impact.


Bodycote measures its performance in this regard using financial and non-financial indicators (shown in the table of Key Performance Indicators below).


Key Performance Indicators for Thermal Processing

 

 


2008


2007*

Financial





    Return on capital employed (1)


10.2%


10.9%

    Return on sales (2)


12.9%


15.1%






Non financial





    ISO 14001 registered facilities 


137


131

    Accident frequency (3)


2.0


2.4


Definitions

(1)  Headline operating profit** as a percentage of average capital employed from continuing operations. Capital employed includes tangible and intangible assets including all previously amortised or impaired historic goodwill and all non-interest bearing assets and liabilities.


(2)  Headline operating profit** as a percentage of revenue from continuing operations.


(3)    Accident frequency - the number of accidents x 200,000 (approximating 100 man years), divided by the total hours worked.


   As restated for Thermal Processing only.

** Headline operating profit, as referred to in this Group Business Review, is defined and reconciled in the   Financial Results for 2008 section.


Return on capital employed and return on sales were both negatively impacted by the downturn in demand in the second half of the year. As a result, a major restructuring of the Thermal Processing business has begun and will continue throughout 2009. In addition to improving efficiency through the closure and consolidation of a number of the Group's facilities, a key focus is the management of people costs.


Bodycote continues to progress towards the target of ensuring that all of the Group's facilities meet the environmental standard ISO 14001. Significant improvements in work related accident rates are being achieved by a combination of training, systems and cultural change.  Bodycote remains committed to achieving the highest standards of safety for its people and having zero accidents remains the goal.


Acquisitions completed since the interim results


Since the interim announcement, the Group has completed the bolt-on acquisition of Bertelmann GmbH in LeverkusenGermanyat a cost of £2.5m.  Bertelmann is a long-standing provider of heat treatment services with a capability that is geared towards the wind energy market. 


Financial Results for 2008 



Revenue 


Headline operating profit


Margin


2008

£m


2007

£m


2008

£m


2007

£m


2008

%



2007

%

Heat Treatment

499.9


421.7


60.0


61.6


12.0


14.6

HIP

51.9


43.5


15.3


15.4


29.5


35.4

Thermal Processing

551.8


465.2


75.3


77.0


13.6


16.6

Head office costs

-


-


(4.1)


(6.7)


-


-

Continuing operations

551.8


465.2


71.2


70.3


12.9


15.1













Discontinued operations

164.9


175.3


20.5


21.0


12.4


12.0

Group Total

716.7


640.5


91.7


91.3


12.8


14.3



Headline operating profit is calculated as follows:

2008

£m


2007

£m

Headline operating profit from continuing operations

71.2


70.3

Amortisation of acquired intangible fixed assets

(1.3)


(0.8)

Impairment of goodwill

(31.9)


(3.5)

Major facility closure costs

(77.6)


(3.4)

Impairment of loan due from associate 

(12.1)


-

Change to pension scheme rules

-


2.6

Bid response costs

-


(2.1)


Operating (loss)/profit from continuing operations 


(51.7)



63.1


The continuing Thermal Processing business and the discontinued Testing business saw solid organic growth until September of 4.6% and 6.4% respectively.  Reduced demand from automotive and general engineering customers in the second half resulted in organic growth for Thermal Processing being restricted to 0.5% for the year as a whole, with a reduction of 0.1% in Heat Treatment and growth of 6.2% in HIP. Acquisitions added 5.9% to Thermal Processing revenues.  The weakness of sterling against most currencies enhanced revenues of the continuing business by 12.2%. 


Demand has remained steady in aerospace, power generation and oil & gas but has weakened markedly in the final quarter of the year in automotive and heavy truck, particularly in FranceGermany and Sweden.  North America has been soft all year in these sectors. Nevertheless outsourcing opportunities remain considerable in all territories and accounted for approximately 20% of Group sales.  


Headline operating profit for continuing operations increased by 1.3% to £71.2m in 2008, with the impact of exchange rates on the translation of overseas profits accounting for £6.5m (9.3% favourable). 


Headline operating margins in the continuing business declined from 15.1% to 12.9% due to the impact of weaker demand in the second half.


During the year the Group acquired three new businesses in the continuing Thermal Processing business at a cost of £16.5m, out of a total of £29.3m spent on acquisitions for the Group as a whole. The Thermal Processing acquisitions in the UK and Germany increase the Group's presence in thermal spray coatings for aerospace and oil & gas customers and in heat treatment for large wind turbine components.


Review of continuing operations - Thermal Processing


Thermal Processing reported sales of £551.8m, an increase of 18.6%. This comprised 0.5% organic, 5.9% acquired and 12.2% in respect of favourable foreign exchange translation impact.  


Heat Treatment 

Heat Treatment saw a growth of 18.5% in revenues to £499.9m representing 90.6% of the continuing group (2007: 90.6%).  Margins were impacted by the economic slowdown and higher energy costs and eased to 12.0% (2007: 14.6%).


With its emphasis on aerospace and power generation, the UK business again saw solid organic growth of 3.6% in 2008. Results from the Nordic region were varied, with the Swedish business impacted by slowing truck and general engineering demand, while Finland was buoyed by continuing strength, particularly for wind energy. The Nordic region in total recorded an organic decline of 1.4%.


Despite the significant downturn in automotive demand in the second half, the Central European countries were still able to post modest organic growth of 0.4%.  Eastern Europe was also impacted by slowing automotive demand towards the end of the year, but the region reported organic growth of 7.4% for the year as a whole. Conversely, France and Belgium have been severely impacted with organic sales down 4.6%.  


North America saw the effect of the global slowdown earlier than Europe. In the US, organic sales were marginally ahead year on year although this was offset by a reduction in the heavily automotive-oriented Canadian business.  North American sales, in total, finished the year 15.8% ahead.  As with other automotive focused markets, the Group's South American business saw a year on year decline in organic sales of 4.0%.


The Group continued to make progress with its developing  Asia business. Sales in 2008 doubled in China and trebled in India, the latter assisted by the opening of a new greenfield location near Pune.


HIP 

With demand continuing to be solid for aerospace, power generation and powder metallurgy (for heavy engineering near-net shapes), organic growth in the European HIP business was satisfactory at 7.9%. Sales increased to £27.3m (2007: £21.7m) including the benefit of the acquisition of TCS in France. Organic growth in North America was 4.4% despite the modest negative effect from the Boeing strike during the second half


Margins were reduced from 35.4% to 29.5%, however following notable capacity increases in North America and Europe (the latter via acquisition of TCS in France) and for which the sales ramp-up is expected to take a least two years.


Restructuring

In light of the global economic downturn, weak demand in the automotive, heavy truck and construction sectors and uncertainty as to the duration of these market conditions, a wide ranging review of the Group's Thermal Processing business has been undertaken.  As a result, the Group has decided to consolidate or close 31 locations (13 in the Americas, 17 in Europe and one in Asia) and to permanently close departments in a number of other facilities. Actions in North America, which entered the downturn sooner, are well underway and are expected to be largely completed in the first half of 2009. In the UK, changes are modest and will be completed during the first quarter of 2009. In mainland Europe some actions will be completed very quickly but in some jurisdictions regulatory requirements mean that the restructuring will not be completed until the end of 2009. The total cost of the reorganisation is expected to be approximately £85m, of which £77.6m has been charged in 2008 and the balance will be charged in 2009 in compliance with IFRS. Of the amount charged in 2008, £42.7m relates to non-cash asset write downs, whilst cash costs are expected to be £34.9m split approximately equally between redundancy payments, site closure costs and environmental remediation.  Environmental remediation is expected to be incurred over approximately five years. The restructuring programme will generate annualised cost savings of approximately £18m once it is completed and headcount will have been reduced by at least 10%.


Goodwill

Each year the Group conducts an assessment of the carrying value of goodwill. With demand currently lower than previously anticipated, the timing of any upturn uncertain and as a consequence of the plan to close or consolidate 31 locations, the Board has concluded that an impairment of £31.9m in the value of the Group's goodwill is appropriate.


Associated company - SSCP Coatings Sarl (SSCP) 

SSCP is a highly leveraged private equity controlled business. In view of the relative ranking of Bodycote's shareholder loans to SSCP and the reduced saleability of such businesses in today's market, a 100% impairment provision of £12.1m has been made in 2008 against the unsecured element of these loans. Bodycote currently owns 24.4% of the share capital of SSCP. 


Review of discontinued operations - Testing


During the 42 weeks to 17 October 2008 (date of sale) Testing recorded sales of £164.9m representing an increase from 2007 on a comparable basis of 12.7%. Of this, 0.5% was organic, 5.4% was due to acquisitions and 6.8% as a result of favourable exchange movements. Up to the point of sale Testing represented 26.8% of total Group revenues and 23.0% for the full year. Headline operating profit was £20.5m for the period to 17 October 2008 (2007: full year £21.0m) and operating profit for the period was £19.9m (2007: full year £15.7m). Headline operating margins increased to 12.4% (2007: 12.0%).


Sale of Testing business


On 28 August 2008 Bodycote announced that it had entered into a conditional sale of its Testing business to CDR Tabasco Limited for a cash consideration of £419.7m on a cash free debt free basis and a vendor loan note in respect of the future sale proceeds of approximately 65 acres of land in Mississauga, Canada. The transaction was completed in accordance with the conditional sale agreement on 17 October 2008.


The net proceeds of the sale after taxation amounted to £378.2m.  Of the sale proceeds £21.0m has been contributed to the Bodycote final salary pension plan, of which £19m was a statutory requirement and £228.4m has been utilised to reduce Group net debt. The remaining £129.5m was returned to shareholders by way of a special distribution of 40 pence per ordinary share on 16 December 2008 of which £128.8m was paid in December 2008 and the remainder will be paid in April 2009.


The after tax gain on sale of £177.4m is reflected in the Group Consolidated Income Statement along with £11.4m profit after tax resulting from trading during the year until the completion of the sale under discontinued operations.


Dividend 


The Board has recommended a final dividend of 5.35p bringing the total dividend to 8.3p per share, an increase of 3.8%. In addition, a special distribution of 40p per ordinary share was paid in December 2008.  The final dividend of 5.35p per share will be paid, subject to approval by shareholders, on 8 May 2009 to all shareholders on the register at close of business on 3 April 2009.


Balance Sheet


 Net assets increased by 0.1% to £496.9m (2007: £496.6m) and net assets per share (weighted average) were up by 2.6% to £1.60 (2007: £1.56). The main changes in the balance sheet arose from the sale of the Testing business, which led to a decrease in net assets (excluding net debt) of £133.2m to £561.6m and a decrease in net debt of £133.5m to £64.7m.


Net Debt


Group net debt was £64.7m (2007: £198.2m).  Had the exchange rates prevailing at 31 December 2007 been applied, the amount would have been net cash of £10.0m.  During the year, additional loans of £86.9were drawn down under committed facilities and gross cash increased by £220.7m to £258.4m.  The Group continues to be able to borrow at competitive rates and therefore currently deems this to be the most effective means of funding. 


Capital expenditure 


Net capital expenditure for the year was £74.9m compared to £66.9m in 2007. The multiple of net capital expenditure to depreciation was 1.3 times (2007: 1.3 times), primarily reflecting the Group's investment in greenfield sites in emerging markets and the expansion of HIP capacity. Given current macro-economic conditions, expenditure in 2009 is expected to be below depreciation. Notable projects in emerging markets with expenditure in 2008 included the construction of heat treatment plants in Silao (Mexico), Bangkok (Thailand) and Rangangaon (India). In addition, a new heat treatment plant in Tampere (Finland) and a new large HIP unit in Surahammar (Sweden) are being built.


Current Trading and Prospects  


Following the sale of the Testing activities Bodycote is a focused business with a strong balance sheet. While automotive markets have softened, demand from aerospace, power generation and oil gas markets remain steady.  


In response to the difficult economic and trading environment, the business is being restructured to ensure it remains strong throughout the downturn and is well positioned to benefit when trading conditions improve. The focus of the restructuring is to both drive down the cost base of the business while at the same time reshaping it to concentrate on those areas that present strong growth opportunities for the future.


Despite the uncertain economic environmentwe remain confident in the medium and long term prospects for the Group.




 





Consolidated Income Statement 




for the year ended 31 December 2008





2008


2007


£m


£m

Revenue




Existing operations

541.4


456.1

Acquisitions

10.4


9.1





Revenue - continuing operations

551.8


465.2





Operating (loss)/ profit




Existing operations

(54.7)


61.8

Acquisitions

3.0


1.2

Share of results of associates

-


0.1

Operating (loss)/profit - continuing operations

(51.7)


63.1





Operating profit prior to exceptional items

71.2


70.3

Amortisation of acquired intangible fixed assets

(1.3)


(0.8)

Impairment of goodwill

(31.9)


(3.5)

Major facility closure costs

(77.6)


(3.4)

Impairment of loan due from associate

(12.1)


-

Change to pension scheme rules

-


2.6

Bid response costs

-


(2.1)





Operating (loss)/profit - continuing operations

(51.7)


63.1





Investment revenue

4.9


2.9

Finance costs

(8.5)


(5.4)

(Loss)/profit before taxation

(55.3)


60.6





Taxation

17.2


(13.6)





(Loss)/profit for the year - continuing operations

(38.1)


47.0





Discontinued operations




Profit for the year - discontinued operations

188.8


6.8





Profit for the year

150.7


53.8





Attributable to:




Equity holders of the parent

149.8


52.8

Minority interests

0.9


1.0






150.7


53.8





Earnings/(loss) per share

Pence


Pence

From continuing operations:




Basic

(12.5)


14.5

Diluted

(12.5)


14.4





From continuing and discontinued operations:




Basic

48.2


16.6

Diluted

48.1


16.6


Consolidated Statement of Recognised Income and Expense 




for the year ended 31 December 2008





2008


2007


£m


£m





Exchange differences on translation of foreign operations

14.2


12.5

Actuarial (losses)/gains on defined benefit pension schemes

(11.4)


4.7

Tax on items taken directly to equity

2.2


(3.1)

Net income recognised directly in equity 

5.0


14.1





Profit for the year

150.7


53.8





Total recognised income/(expense) for the year

155.7


67.9





Attributable to:




Equity holders of the parent

154.8


66.9

Minority interests

0.9


1.0






155.7


67.9










  

Consolidated Balance Sheet




at 31 December 2008





2008


2007


£m


£m

Non-current assets




Goodwill

141.6


213.0

Other intangible assets

12.8


14.3

Property, plant and equipment

533.3


508.9

Interests in associates

8.2


0.6

Finance lease receivables

0.7


1.0

Deferred tax asset

52.5


29.7

Derivative financial instruments

-


0.1

Trade and other receivables

3.0


13.3


752.1


780.9





Current assets




Inventories

14.0


19.8

Finance lease receivables

0.4


0.4

Derivative financial instruments

1.8


-

Trade and other receivables

128.4


159.3

Cash and cash equivalents

258.4


37.7

Assets classified as held for sale

3.6


1.8


406.6


219.0

Total assets

1,158.7


999.9





Current liabilities




Trade and other payables

118.9


124.5

Dividends payable

9.4


8.8

Current tax liabilities

33.6


13.0

Obligations under finance leases

1.2


1.7

Borrowings

16.3


9.0

Derivative financial instruments

26.3


5.2

Provisions

27.2


5.7


232.9


167.9





Net current assets

173.7


51.1





Non-current liabilities




Borrowings

302.9


221.8

Retirement benefit obligations

14.9


23.9

Deferred tax liabilities

78.3


74.3

Obligations under finance leases

2.7


3.4

Derivative financial instruments

5.2


3.0

Provisions

15.5


2.2

Other payables

9.4


6.8


428.9


335.4

Total liabilities

661.8


503.3





Net assets

496.9


496.6





Consolidated Balance Sheet (continued)




at 31 December 2008





2008


2007


£m


£m

Equity




Share capital

32.4


32.4

Share premium account

175.7


305.0

Own shares

(10.9)


(11.0)

Other reserves

137.3


6.0

Hedging and translation reserves

31.1


16.9

Retained earnings

126.4


140.7





Equity attributable to equity holders of the parent

492.0


490.0





Minority interest

4.9


6.6





Total equity

496.9


496.6



Consolidated Cash Flow Statement




for the year ended 31 December 2008





2008


2007


£m


£m





Net cash from operating activities

102.5


108.0





Investing activities




Purchases of property, plant and equipment

(77.1)


(72.5)

Proceeds on disposal of property, plant and equipment and intangible assets

4.6


6.6

Purchases of intangible fixed assets

(2.4)


(1.0)

Acquisition of investment in an associate

(5.6)


(0.2)

Acquisition of subsidiaries

(29.3)


(32.7)

Disposal of subsidiaries

400.1


-

Lump sum contribution to pension scheme

(21.0)


-





Net cash received from/( used in) investing activities

269.3


(99.8)





Financing activities




Interest received

12.5


3.4

Interest paid

(20.5)


(12.5)

Dividends paid

(154.3)


(22.6)

Dividends paid to a minority shareholder

(0.1)


(0.1)

Repayments of bank loans

(6.0)


(187.1)

Payments of obligations under finance leases

(2.6)


(1.9)

New bank loans raised

8.0


216.4

New obligations under finance leases

0.3


0.6

Proceeds on issue of ordinary share capital

0.2


3.1

Own shares purchased/settlement of share options

0.1


(8.6)





Net cash used in financing activities

(162.4)


(9.3)





Net increase/(decrease) in cash and cash equivalents

209.4


(1.1)





Cash and cash equivalents at beginning of year

34.3


33.4





Effect of foreign exchange rate changes

5.8


2.0





Cash and cash equivalents at end of year

249.5


34.3



Reconciliation of profit for the year to net cash from operating activities




2008


2007


£m


£m





Profit for the year

150.7


53.8





Adjustments for:




Investment revenues - continuing and discontinued

(5.7)


(3.3)

Finance costs - continuing and discontinued

15.7


13.6

Taxation - continuing and discontinued

6.8


14.7

Depreciation of property, plant and equipment

57.8


49.3

Amortisation of intangible assets

2.9


2.3

Loss/(gain) on disposal of property, plant and equipment

0.1


(0.1)

Income from associates

-


(0.1)

Share-based payments

2.6


2.5

Impairment of intangible assets acquired through business combinations

-


0.4

Impairment of goodwill

31.9


7.2

Major facility closure costs

42.7


5.4

Impairment of loan due from associate

12.1


-

Gain on disposal of discontinued operations

(199.3)


-

Change to pension scheme rules

-


(4.1)

Bid response costs

-


2.1





EBITDA1

118.3


143.7





Decrease/(increase) in inventories

1.5


(3.7)

Decrease/(increase) in receivables

2.3


(8.4)

Decrease in payables

(16.8)


(2.9)

Increase/(decrease) in provisions

30.6


(5.4)





Cash generated by operations

135.9


123.3

Cash (outflow)/inflow from settlement of derivative financial instruments

(12.9)


0.7

Income taxes paid

(20.5)


(16.0)





Net cash from operating activities

102.5


108.0





1 Earnings before interest, tax, depreciationamortisation, impairment and share-based payments


Cash and cash equivalents (which are presented as a single class of assets on the face of the balance sheet) comprise cash at bank and other short-term highly liquid investments with a maturity of three months or less.




  

1. Operating (loss)/ profit









2008


2007


Existing operations

Acquisitions

Continuing operations


Existing operations

Acquisitions

Continuing operations


£m

£m

£m


£m

£m

£m









Revenue

541.4

10.4

551.8


456.1

9.1

465.2

Cost of sales

(371.0)

(6.0)

(377.0)


(301.7)

(5.6)

(307.3)









Gross profit

170.4

4.4

174.8


154.4

3.5

157.9









Other operating income

6.0

-

6.0


4.5

0.2

4.7

Distribution costs

(20.0)

(0.3)

(20.3)


(15.4)

(0.7)

(16.1)

Other administration expenses*

(88.2)

(1.0)

(89.2)


(74.5)

(1.8)

(76.3)

Other operating expenses

-

(0.1)

(0.1)


-

-

-

Amortisation/impairment of acquired intangible fixed assets*

(1.3)

-

(1.3)


(0.8)

-

(0.8)

Impairment of goodwill*

(31.9)

-

(31.9)


(3.5)

-

(3.5)

Major facility closure costs*

(77.6)

-

(77.6)


(3.4)

-

(3.4)

Impairment of loan due from associate*

(12.1)

-

(12.1)


-

-

-

Change to pension scheme rules*

-

-

-


2.6

-

2.6

Bid response costs*

-

-

-


(2.1)

-

(2.1)









Operating (loss)/profit before income from associates

(54.7)

3.0

(51.7)


61.8

1.2

63.0









Income from associates after interest and tax



-




0.1









Operating (loss)/profit



(51.7)




63.1









* Administration expenses (total £212.1m, 2007: £83.5m)















Exceptional items comprise:





2008

£m


2007

£m









Amortisation of acquired intangible fixed assets


1.3


0.8

Impairment of goodwill





31.9


3.5

Major facility closure costs



77.6


3.4

Impairment of loan due from associate



12.1


-

Change to pension scheme rules



-


(2.6)

Bid response costs





-


2.1







122.9


7.2


  

2. Business and geographical segments














Heat Treatment

Hot Isostatic Pressing

Head Office and eliminations

Consolidated

Discontinued operations

(Testing)

Total Group

2008

2008

2008

2008

2008

2008

£m

£m

£m

£m

£m

£m

Revenue







Total revenue

499.9

51.9

-

551.8

164.9

716.7








Result







Segment result prior to exceptional items and share of associates' profit after tax

60.0

15.3

-

75.3

20.5

95.8

Unallocated corporate expenses

-

-

(4.1)

(4.1)

-

(4.1)

Headline operating profit

60.0

15.3

(4.1)

71.2

20.5

91.7

Amortisation /impairment of acquired intangible assets and impairment of goodwill 

(33.2)

-

-

(33.2)

(0.6)

(33.8)

Major facility closure costs

(77.1)

(0.5)

-

(77.6)

-

(77.6)

Impairment of loan due from associate

-

-

(12.1)

(12.1)

-

(12.1)

Disposal of Testing business

-

-

-

-

199.3

199.3








Segment result

(50.3)

14.8

(16.2)

(51.7)

219.2

167.5








Investment revenue




4.9



Finance costs




(8.5)




Loss before tax




(55.3)



Tax




17.2



Profit for the period from discontinued operations




188.8










Profit for the year




150.7










Following the disposal of the Testing business, which was formerly disclosed as two segments, the Directors concluded that presentation as a single segment within discontinued operations is most appropriate. The prior year comparatives have been re-presented accordingly.


Inter-segment sales are not material in either year.

  

2. Business and geographical segments (continued)













Heat Treatment

Hot Isostatic Pressing

Head Office and eliminations

Consolidated

Discontinued operations

(Testing)

Total Group

2007

2007


2007

2007

2007

2007

£m

£m

£m

£m

£m

£m

Revenue







Total revenue

421.7

43.5

-

465.2

175.3

640.5








Result







Segment result prior to exceptional items and share of associates' profit after tax

61.6

15.3

-

76.9

21.0

97.9

Share of associates' operating profit

-

0.1

-

0.1

-

0.1

Unallocated corporate expenses

-

-

(6.7)

(6.7)

-

(6.7)

Headline operating profit

61.6

15.4

(6.7)

70.3

21.0

91.3

Amortisation /impairment of acquired intangible assets and impairment of goodwill 

(4.3)

-

-

(4.3)

(4.8)

(9.1)

Major facility closure costs

(3.4)

-

-

(3.4)

(2.0)

(5.4)

Changes to pension scheme rules

2.0

0.2

0.4

2.6

1.5

4.1

Bid response costs

-

-

(2.1)

(2.1)

-

(2.1)








Segment result

55.9

15.6

(8.4)

63.1

15.7

78.8








Investment revenue




2.9



Finance costs




(5.4)




Profit before tax




60.6



Tax




(13.6)



Profit for the year from discontinued operations




6.8










Profit for the year




53.8













  

2. Business and geographical segments (continued)





Other information    













Heat Treatment

Hot Isostatic Pressing

Discontinued

Operations (Testing)

Head Office and eliminations

Consolidated


2008

2008

2008

2008

2008


£m

£m

£m

£m

£m







Capital additions

58.1

7.7

11.7

2.0

79.5

Depreciation and amortisation

43.7

6.1

10.6

0.2

60.6

Impairment losses recognised in income

72.6

0.4

-

12.1

85.1







Balance sheet






Assets:






    Segment assets

816.6

106.7

-

227.2

1,150.5

    Interests in associates

8.2

-

-

-

8.2







Consolidated total assets

824.8

106.7

-

227.2

1,158.7







Liabilities:






Segment liabilities

235.3

29.2

-

397.3

661.8







Segment net assets

589.5

77.5

-

(170.1)

496.9














Heat Treatment

Hot Isostatic Pressing

Discontinued

Operations (Testing)

Head Office and eliminations

Consolidated

2007

2007

2007

2007

2007

£m

£m

£m

£m

£m







Capital additions

44.2

12.6

16.2

0.5

73.5

Depreciation and amortisation

36.0

4.3

11.1

0.2

51.6

Impairment losses recognised in income

3.8

-

4.5

-

8.3







Balance sheet






Assets:






Segment assets

941.4

100.2

235.3

(277.6)

999.3

Interests in associates

0.6

-

-

-

0.6







Consolidated total assets

942.0

100.2

235.3

(277.6)

999.9







Liabilities:






Segment liabilities

522.9

48.2

165.4

(233.2)

503.3







Segment net assets

419.1

52.0

69.9

(44.4)

496.6



2.    Business and geographical segments (continued)














    By geographical market












Revenue






2008


2007






£m


£m

    Europe, Middle East and Africa




379.4


317.4

    Americas





168.8


146.6

    Asia Pacific





3.6


1.2














551.8


465.2









Revenue from the Group's discontinued operations was derived principally from Europe, Middle East and Africa £100.2m (2007: £104.6m), Americas £62.3m (2007: £68.8m) and Asia Pacific £2.4m (2007: £1.9m).






Carrying amount of segment assets/liabilities


Additions to property, plant and equipment and intangible assets


2008


2007


2008


2007


£m


£m


£m


£m

Europe, Middle East and Africa

366.1


395.1



53.6



45.4

Americas

131.1


101.0


19.0


24.0

Asia Pacific

(0.3)


0.5


6.9


4.1










496.9


496.6


79.5


73.5


  

3.    Taxation








Continuing operations

Discontinued operations

Total


2008

£m

2007

£m

2008

£m

2007

£m

2008

£m

2007

£m







Current taxation - charge for the year

12.9

14.2

23.6

2.8

36.5

17.0

Current taxation - adjustments in respect of previous years

0.2

0.4

0.3

3.0

0.5

3.4

Deferred tax

(30.3)

(1.0)

0.1

(4.7)

(30.2)

(5.7)



(17.2)

13.6

24.0

1.1

6.8

14.7








UK corporation tax is calculated at 28.5% (2007: 30.0%) of the estimated assessable profit for the year. Taxation for other jurisdictions is calculated at the rates prevailing in the respective jurisdictions.








Of the total charge/(credit) to current tax, approximately £2.0m (2007: £5.8m) related to profits arising in the Testing business, which was disposed of during the year. A tax charge of £21.9m arose on the disposal of the various subsidiaries which comprised the business.








The charge for the year can be reconciled to the profit per the income statement as follows:








2008

£m

2007

£m


(Loss)/profit before tax:



    Continuing operations

(55.3)

60.6

    Discontinued operations

212.8

7.9







157.5

68.5








Tax at the UK corporation tax rate of 28.5% (2007: 30.0%)

44.9

20.6

Tax effect of expenses that are not deductible in determining taxable profit

20.2

0.7

Tax effect of non-taxable disposal proceeds


(39.2)

-

Deferred tax assets not recognised

1.7

(0.2)

Tax settlements in respect of prior years


(8.6)

(1.6)

Tax effect of other adjustments in respect of previous periods


(2.2)

(2.6)

Effect of different tax rates of subsidiaries operating in other jurisdictions


(10.0)

(2.2)








Tax expense for the year





6.8

14.7








The tax credit on items taken directly to equity is £2.2m (2007: charge £3.1m)





  

4.    Earnings/(loss) per share










The calculation of the basic and diluted earnings/(loss) per share is based on the following data:









2008


2007



£m


£m

Earnings





Earnings for the purpose of basic earnings per share being net profit attributable to equity holders of the parent


149.8


52.8






Number of shares







Number


Number

Weighted average number of ordinary shares for the purposes of basic earnings per share


310,936,573


317,934,910






Effect of dilutive potential ordinary shares:





Share options


239,456


732,862






Weighted average number of ordinary shares for the purposes of diluted earnings per share


311,176,029


318,667,772






From continuing operations


2008


2007



£m


£m

    Earnings/(loss)





Net profit attributable to equity holders of the parent


149.8


52.8






Adjustments to exclude profit for the year from discontinued operations


(188.8)


(6.8)






(Loss)/earnings from continuing operations for the purpose of basic (loss)/ earnings per share excluding discontinued operations


(39.0)


46.0






The denominators used are the same as those detailed above for both basic and diluted earnings per share from continuing and discontinued operations






Earnings per share from continuing and discontinued

operations:





Pence


Pence

Basic


48.2


16.6






Diluted


48.1


16.6






Earnings per share from discontinued operations:


Pence


Pence






Basic


60.7


2.1






Diluted


60.7


2.1







4.    Earnings/(loss) per share (continued)










(Loss)/earnings per share from continuing operations:


Pence


Pence






Basic


(12.5)


14.5






Diluted


(12.5)


14.4











Headline earnings


2008


2007



£m


£m

Net profit attributable to equity holders of the parent


149.8


52.8






Add back:





Impairment of goodwill


31.4


3.5

Amortisation of acquired intangible fixed assets


1.2


0.8

Impairment of loan due from associate


8.7


-

Major facility closure costs


52.0


2.3

Change to pension scheme rules


-


(1.9)

Bid response costs


-


2.1

Profit for the year - discontinued operations


(188.8)


(6.8)






Headline earnings


54.3


52.8






Earnings per share from headline earnings:







Pence


Pence






Basic


17.5


16.6






Diluted


17.4


16.6


  

5.    Basis of preparation


The financial information has been based on the company's financial statements which are prepared in accordance with International Financial Reporting Standards (IFRS) as adopted for use in the EU. 


Whilst the financial information contained in this preliminary announcement has been computed in accordance with International Financial Reporting Standards, this announcement does not itself contain sufficient information to comply with IFRS. The Company expects to publish full financial statements that comply with IFRS in April 2009.


The financial information has been prepared under the same accounting policies as the 2007 financial statements.


6.    Non-statutory financial statements


The financial information set out above does not constitute the Group's statutory financial statements for the year ended 31 December 2008 or 2007 but is derived from those financial statements. Statutory financial statements for 2007 have been delivered to the Registrar of Companies. Those for 2008 will be delivered following the company's annual general meeting, which will be convened on 27 April 2009. The auditors have reported on those accounts: their report was unqualified, did not draw attention to any matters by way of emphasis without qualifying their report and did not contain any statements under Section 237(2) or (3) of the Companies Act 1985.


This report was approved by the Board of Directors on 25 February 2009.





This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FZLLLKLBLBBB

Companies

Bodycote (BOY)
UK 100

Latest directors dealings